Israel Englander Beam Therapeutics Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Millennium Management LLC holds 80,844 shares of BEAM stock, worth $2.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

80,844

Previous 107,187 24.58%

Holding current value

$2.15 Million

Previous $3.54 Million 46.51%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$21.22 - $32.66 $558,998 - $860,362	-26,343 Reduced 24.58%	80,844 $1.89 Million
Q1 2024 May 15, 2024	BUY	$23.46 - $45.07 $738,473 - $1.42 Million	31,478 Added 41.58%	107,187 $3.54 Million
Q4 2023 Feb 14, 2024	SELL	$17.69 - $30.76 $2.12 Million - $3.69 Million	-119,822 Reduced 61.28%	75,709 $2.06 Million
Q2 2023 Aug 14, 2023	BUY	$29.32 - $35.99 $74,208 - $91,090	2,531 Added 1.31%	195,531 $6.24 Million
Q1 2023 May 15, 2023	BUY	$30.15 - $48.79 $3.43 Million - $5.55 Million	113,846 Added 143.83%	193,000 $5.91 Million
Q4 2022 Feb 14, 2023	SELL	$36.73 - $51.6 $3.27 Million - $4.59 Million	-88,951 Reduced 52.91%	79,154 $3.1 Million
Q3 2022 Nov 14, 2022	SELL	$39.79 - $70.31 $9.24 Million - $16.3 Million	-232,258 Reduced 58.01%	168,105 $8.01 Million
Q2 2022 Aug 15, 2022	SELL	$29.86 - $62.36 $5.31 Million - $11.1 Million	-177,698 Reduced 30.74%	400,363 $15.5 Million
Q1 2022 May 16, 2022	BUY	$53.73 - $82.16 $23.5 Million - $35.9 Million	437,411 Added 310.99%	578,061 $33.1 Million
Q4 2021 Feb 14, 2022	SELL	$68.02 - $99.06 $5.87 Million - $8.55 Million	-86,339 Reduced 38.04%	140,650 $11.2 Million
Q3 2021 Nov 15, 2021	BUY	$84.37 - $133.6 $11.1 Million - $17.5 Million	131,294 Added 137.2%	226,989 $19.8 Million
Q2 2021 Aug 16, 2021	SELL	$64.12 - $128.71 $6.32 Million - $12.7 Million	-98,600 Reduced 50.75%	95,695 $12.3 Million
Q1 2021 May 17, 2021	BUY	$71.28 - $120.75 $10.7 Million - $18.1 Million	149,824 Added 336.9%	194,295 $14.8 Million
Q4 2020 Feb 16, 2021	BUY	$22.24 - $95.63 $989,035 - $4.25 Million	44,471 New	44,471 $3.63 Million
Q3 2020 Nov 16, 2020	SELL	$19.0 - $30.57 $6.43 Million - $10.4 Million	-338,645 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$15.26 - $28.66 $1.92 Million - $3.6 Million	125,540 Added 58.91%	338,645 $9.48 Million
Q1 2020 May 14, 2020	BUY	$13.31 - $29.2 $2.84 Million - $6.22 Million	213,105 New	213,105 $3.84 Million

Others Institutions Holding BEAM

# of Institutions

229

Shares Held

71.8M

Call Options Held

283K

Put Options Held

233K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.87B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account